Senior finance executive and investor focused on growth-stage consumer and healthcare opportunities, with experience across corporate finance, strategy and board advisory. Cathleen Wrisberg has led capital-raising and M&A initiatives, advised management teams on go-to-market and scaling, and participates in private equity and venture investments. Market-oriented profile suited for board, advisory, and deal-sourcing roles.
Senior finance executive and investor focused on growth-stage consumer and healthcare opportunities, with experience across corporate finance, strategy and board advisory. Cathleen Wrisberg has led capital-raising and M&A initiatives, advised management teams on go-to-market and scaling, and participates in private equity and venture investments. Market-oriented profile suited for board, advisory, and deal-sourcing roles.
Focuses on growth-stage consumer and healthcare investments, prioritizing companies with repeatable unit economics and clear go‑to‑market paths. Prefers active, board-level engagement to drive capital efficiency, commercial scaling, and M&A preparation. Allocates capital with a medium-to-long horizon, blending venture and private equity instruments, and uses corporate finance experience to structure rounds and exits. Underwriting emphasizes operational KPIs, defensible customer acquisition economics, and regulatory awareness in healthcare. Risk discipline centers on staged capital deployment, milestone-based follow-ons, and alignment with management.
Focuses on growth-stage consumer and healthcare investments, prioritizing companies with repeatable unit economics and clear go‑to‑market paths. Prefers active, board-level engagement to drive capital efficiency, commercial scaling, and M&A preparation. Allocates capital with a medium-to-long horizon, blending venture and private equity instruments, and uses corporate finance experience to structure rounds and exits. Underwriting emphasizes operational KPIs, defensible customer acquisition economics, and regulatory awareness in healthcare. Risk discipline centers on staged capital deployment, milestone-based follow-ons, and alignment with management.
| Trades 1891 | Longs Won 1253/1891 66% | Profit Factor 4.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $501,051.91 |
| Average Win $175,375.34 | Best Trade (Oct 15) $8.14M | Sharpe Ratio -9.5 |
| Average Loss -$69,705.08 | Worst Trade (Oct 15) -$2.23M | Z-Score 9.11 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 1w 5d | Expectancy $92,688.24 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,857 | 16,071 | 14,286 | 12,500 | 10,714 | 8,929 | 7,143 | 5,357 | 3,571 | 1,786 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 76,656 | $19.09M | $26.53M | - | $7.44M | 38.97% | -0.594% |
ABBV AbbVie Inc. | 5,670 | $1.29M | $1.62M | - | $326,425.1 | 25.21% | +0.256% |
ACN Accenture plc | 9,284 | $1.84M | $2.29M | - | $444,172.85 | 24.1% | -4.798% |
ACWX iShares MSCI ACWI ex U.S. ETF | 4,418 | $336,254 | $324,060.3 | - | -$12,193.7 | -3.63% | -0.407% |
ADI Analog Devices, Inc. | 2,488 | $778,055.19 | $969,374.56 | - | $191,319.37 | 24.59% | +1.001% |
AEP American Electric Power Company, Inc. | 3,169 | $424,191.74 | $408,246.42 | - | -$15,945.32 | -3.76% | -1.389% |
AER AerCap Holdings N.V. | 6,218 | $879,520.26 | $899,868.96 | - | $20,348.7 | 2.31% | -2.004% |
AFL Aflac Incorporated | 7,584 | $776,794.54 | $911,596.8 | - | $134,802.26 | 17.35% | -2.49% |
AIQ Global X Artificial Intelligence & Technology ETF | 4,000 | $262,440 | $249,120 | - | -$13,320 | -5.08% | +0.338% |
ALL The Allstate Corporation | 16,689 | $3.36M | $4.23M | - | $867,039.69 | 25.82% | -2.281% |
AM Antero Midstream Corporation Common Stock | 20,414 | $430,297.13 | $427,775.37 | - | -$2,521.76 | -0.59% | +1.674% |
AMAT Applied Materials Inc. | 1,710 | $834,887.38 | $649,646.1 | - | -$185,241.28 | -22.19% | +1.153% |
AMD Advanced Micro Devices Inc. | 3,850 | $1.47M | $1.98M | - | $512,482.47 | 34.86% | +1.384% |
AME AMETEK, Inc. | 22,589 | $4.64M | $5.41M | - | $769,205.72 | 16.56% | +0.341% |
AMGN Amgen Inc. Common Stock | 3,673 | $1.2M | $1.62M | - | $424,675.16 | 35.46% | -1.246% |
AMT American Tower Corporation | 1,638 | $267,955 | $307,894.86 | - | $39,939.86 | 14.91% | +3.525% |
AMZN Amazon.com Inc | 63,086 | $13.57M | $15.72M | - | $2.15M | 15.84% | -0.491% |
APH Amphenol Corp. Class A Common Stock | 12,640 | $258,871.58 | $936,876.8 | - | $678,005.22 | 261.91% | +1.437% |
ARKK ARK Innovation ETF | 7,168 | $447,433.09 | $586,270.72 | - | $138,837.63 | 31.03% | -0.086% |
ARM Arm Holdings plc ADR | 9,894 | $2.13M | $2.08M | - | -$43,127.2 | -2.03% | +0.243% |